In addition, ATP1B3 was recently reported to be a novel determinant of pain variability [35] and impairment of the Na+/K+-ATPase β subunit increased the incidence of apoptosis among leukaemia cells [36, 37]; however, the complete oncogenic role of ATP1B3 in gastric cancer is still unclear. The gene discussed is ATP1B3; the disease is leukemia.